< Back to latest news & events

Knowledge Hub

UPC’s Hamburg Local Division provides guidance on the extent to which a patent may be used as its own “lexicon”

June 2025

Agfa NV v Gucci & Anors. [UPC_CFI_278/2023] – Hamburg Local Division of the UPC (Klepsch, Schilling, Sarlin) – 30 April 2025

While we await a decision on G1/24 from the EPO’s Enlarged Board of Appeal on claim interpretation, the UPC’s Hamburg Local Division (LD) has provided guidance on the extent to which a patent may be used as its own “lexicon”.  In apparent contrast to the decision of the EPO’s Technical Board of Appeal in T56/21 that there was no legal basis for adapting the description to the granted claims, the LD took the view that there were several passages in the description of the patent-in-suit that “should have been deleted” in the light of the amendments made to the patent during examination.  The LD found that these parts of the description to be inconsistent with the granted claims and, accordingly, could not serve as a basis for a broad interpretation of the claims.

Background

This case concerned Agfa’s patent to the manufacture of decorated natural leather and leather articles by inkjet printing. The patented method involved applying a base coat containing a pigment for providing an “achromatic colour” to the leather, and then inkjet printing a colour image onto the base coat. Agfa sued Gucci, while Gucci counterclaimed for revocation of the patent.

The dispute centred on the interpretation of the meaning of the term “achromatic colour”.  The independent claim of the patent[1] referred to a “base coat containing a pigment for providing an achromatic colour different from black”. There was agreement among the parties that the term “achromatic” referred to the base coat as a whole rather than the pigment per se, and that the “achromatic colour” was a colour different from black. However, there was disagreement as to what constituted an “achromatic colour” beyond the requirement that it was different from black.

The Judgment

As is now the UPC’s established practice, the Hamburg LD emphasised that the terms used in the claims governed claim construction[2].  They were not just the “starting point” for claim construction but the authoritative basis for determining the scope of protection.  Nevertheless, the description and drawings always had to be considered, even when interpreting seemingly clear terms.  Accordingly, in line with UPC Court of Appeal’s approach in Nanostring v 10x Genomics [UPC_CoA_335/2023], the LD confirmed that a patent could be used as its “own lexicon”.

In the case at hand, the LD construed the “achromatic colour” in the light of paragraph [0021], which contained a definition of the achromatic base coat.  This passage indicated that a chromatic colour was any colour in which one particular wavelength predominated. Blue and green were provided as examples of chromatic colours, while white, grey and black were given as examples of achromatic colours.  The latter colours were said to have no dominant hue, meaning that all wavelengths were present in approximately equal amounts within those colours.

The cases for infringement and validity centred on whether ivory could be considered as an “achromatic colour”.  Applying the definition in paragraph [0021] that all wavelengths had to be present in approximately equal amounts, the LD did not consider an ivory base coat to be “achromatic” within the meaning of the claim because the wavelength requirement was not met. In reaching this conclusion, the LD took the view that, although the patent saw e.g., white and grey as achromatic colours, it was clear to a skilled person that not all white and grey tones fulfilled the patent’s definition of achromatic, as some white or grey tones would not have all wavelengths present in approximately equal amounts.

The LD’s construction of “achromatic colour” may have been disappointing to Agfa because parts of the description of its patent described base coats having off-white, pale clay and pale yellow colours.  Notably, paragraph [0029] of the patent mentioned “a base coat containing white pigment and one or more colour pigments to provide e.g., an off-white or pale clay colour”.  Similarly, Example 3 described the base coat having a “pale yellow (clay colour)”.

In the LD’s view, however, those parts of the text did not support Agfa’s contention that all off-white base coats were within the scope of the claim, because the application as originally filed concerned both chromatic and achromatic colours. The reference to chromatic colour, however, was deleted during the course of examination of the application. Accordingly, the LD saw the “off-white”, “pale clay” and “pale yellow” embodiments as no longer falling within the scope of claim 1 as amended, as they did not have wavelengths presented in approximately equal amounts.  As such, the LD simply saw the “off-white”, “pale clay” and “pale yellow” embodiments as inconsistencies with the granted claims that “should have been deleted”. Their inclusion in the description could not override the clear definition given in paragraph [0021] because of the need for legal certainty.

Conclusion

This case highlights the risk of including narrow definitions of terms in patents. Even if a patent contains examples that arguably support a broader interpretation of a claim, patent owners may not be able to rely on these examples to justify a broad interpretation of the claim if a term is defined more narrowly elsewhere in the text. Although the LD in this case took pains to explain that the prosecution history was not taken into account in all aspects, the LD nonetheless took note of the way the claims had been amended during examination. This influenced its conclusion that the broader examples were inconsistencies that “should have been deleted” when adapting the description to the allowed claims.

While we await the Enlarged Board’s decision on G1/24, it remains to be seen what approach the EPO will adopt when interpreting claims. While the Enlarged Board has indicated that it will provide more clarity on the role of the description in interpreting claims, it is not yet clear whether the Enlarged Board will also tackle the issue of adapting the description.  The latter was not a question formally put forward in G1/24.  However, the President of the EPO considered the question of whether adapting the description was mandatory to be important when considering whether claims should be interpreted in the light of the description[3]. This seems in line with the reasoning applied by the LD in this UPC judgment.

[1] EP3388490

[2] in line with Article 69 EPC and its Protocol

[3] See paragraph 87 of the President’s submissions of 7 November 2024 on G1/24


This article was written by Partner and Patent Attorney Hsu Min Chung

Latest updates

Event - 24th June 2026

IP Clinic for SMEs at ETZ EnergyWorks

Following the success of our first session, we’re pleased to announce our next Intellectual Property (IP) clinic taking place at ETZ EnergyWorks in Aberdeen on Wednesday 24 June 2026, from …

Event details
Event - 2nd June 2026

HGF are proud sponsors of Retail Week General Counsel 2026

HGF is proud to be sponsoring Retail Week General Counsel. This will take place on Wednesday 3rd June at Ham Yard Hotel. The retail legal landscape is undergoing a fundamental …

Event details
Event - 5th May 2026

IP Clinic for SMEs at ETZ EnergyWorks

We’re pleased to announce a free Intellectual Property (IP) clinic taking place at ETZ EnergyWorks in Aberdeen on Wednesday 27th May, from 11.00am to 4.00pm, designed to support SMEs in …

Event details
Event - 11th - 12th May 2026

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe.

HGF is proud to be attending the 14th Microbiome R&D and Business Collaboration Forum: Europe 8th Skin Microbiome and Cosmeceuticals Congress: Europe. It will be held on Monday 11-12th May …

Event details
Event - 27th April 2026

HGF are proud to be Gold Sponsors of IP Counsel Café

HGF are proud to be Gold Sponsors of IP Counsel Café on 12-14th May at Silicon Valley, US. HGF Partner Susan Keston will be speaking at on the topic AI …

Event details
Event - 16th April 2026

MedTech Innovation Summit 2026

HGF Partner and Patent Attorney Adam Hines will be attending the MedTech Innovation Summit Dublin 2026, taking place from 28–30 April at The Shelbourne Hotel. As one of Europe’s premier …

Event details
Event - 2nd - 6th May 2026

INTA 2026 Annual Meeting

HGF’s European team are delighted to be attending the INTA Annual Meeting 2026, taking place from 2nd-6th May in London. As one of Europe’s leading IP firms, HGF brings together …

Event details
Event - 25th March 2026

HGF Women IP Inclusive Event

HGF are hosting Connected Bubbles Networking Event on Wednesday 25 March 2026 and this year they are teaming up with CIPA! In a profession built on collaboration, referrals and trusted …

Event details